Merck posts two Phase 3 trials, sotatercept in HFpEF and sac-TMT in bladder cancerSep 24Weekly roundup, 4 itemsMerck & Co., Inc.sotatercept-csrk
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.